|
| IRG 1 | Full name | IRG 2 | Full name | Lasso coefficient |
|
| FGF9 | Fibroblast growth factor 9 | MICB | MHC class I polypeptide-related sequence B | 0.2288 |
| CMKLR1 | Chemokine-like receptor 1 | BIRC5 | Baculoviral IAP repeat-containing 5 | 0.1965 |
| VIPR2 | Vasoactive intestinal peptide receptor 2 | GIPR | Gastric inhibitory polypeptide receptor | 0.3493 |
| ELANE | Elastase, neutrophil expressed | IL9R | Interleukin 9 receptor | 0.2896 |
| GHR | Growth hormone receptor | FLT4 | Fms-related tyrosine kinase 4 | 0.0652 |
| ELANE | Elastase, neutrophil expressed | ANGPTL6 | Angiopoietin-like 6 | 0.0617 |
| PCSK2 | Proprotein convertase subtilisin/kexin type 2 | FGF1 | Fibroblast growth factor 1 | 0.0177 |
| RORB | RAR-related orphan receptor B | GALR2 | Galanin receptor 2 | 0.2577 |
| EDNRB | Endothelin receptor type B | AGER | Advanced glycosylation end product-specific receptor | 0.0772 |
| LCN6 | Lipocalin 6 | TNFSF11 | Tumor necrosis factor superfamily, member 11 | 0.1041 |
| MASP1 | Mannan-binding lectin serine peptidase 1 | CSF2 | Colony stimulating factor 2 | 0.1981 |
| AHNAK | AHNAK nucleoprotein | PSMD8 | Proteasome 26S subunit, non-ATPase, 8 | 0.2832 |
| IL16 | Interleukin 16 | APOBEC3H | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H | 0.0421 |
| PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | VAV2 | VAV 2 guanine nucleotide exchange factor | 0.0141 |
| FGF9 | Fibroblast growth factor 9 | CST4 | Cystatin S | 0.0840 |
| GHR | Growth hormone receptor | LHB | Luteinizing hormone beta polypeptide | 0.0237 |
| LCN6 | Lipocalin 6 | IL13RA2 | Interleukin 13 receptor, alpha 2 | 0.3899 |
| OGN | Osteoglycin | NOX4 | NADPH oxidase 4 | 0.0529 |
| SFTPD | Surfactant protein D | ESM1 | Endothelial cell-specific molecule 1 | 0.3064 |
| TNC | Tenascin C | SPP1 | Secreted phosphoprotein 1 | 0.2258 |
| CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | MPL | Myeloproliferative leukemia virus oncogene | 0.1306 |
| LTBP4 | Latent transforming growth factor beta binding protein 4 | VAV2 | VAV 2 guanine nucleotide exchange factor | 0.1395 |
| FGF13 | Fibroblast growth factor 13 | CST4 | Cystatin S | 0.0819 |
| NR2F1 | Nuclear receptor subfamily 2, group F, member 1 | ESM1 | Endothelial cell-specific molecule 1 | 0.0037 |
| NR2F1 | Nuclear receptor subfamily 2, group F, member 1 | TCF7L2 | Transcription factor 7-like 2 | 0.1656 |
| PIK3R3 | Phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | RAC3 | Ras-related C3 botulinum toxin substrate 3 | −0.1612 |
| BMP5 | Bone morphogenetic protein 5 | OXTR | Oxytocin receptor | −0.2999 |
| HLA-DOA | Major histocompatibility complex, class II, DO alpha | RAC3 | Ras-related C3 botulinum toxin substrate 3 | −0.1058 |
| NTF3 | Neurotrophin 3 | NOX4 | NADPH oxidase 4 | −0.1384 |
| PRF1 | Perforin 1 | RAC3 | Ras-related C3 botulinum toxin substrate 3 | −0.1295 |
| IL10RA | Interleukin 10 receptor, alpha | TOR2A | Torsin family 2, member A | −0.1601 |
| LIFR | Leukemia inhibitory factor receptor alpha | CALCRL | Calcitonin receptor-like | −0.2448 |
| JAK2 | Janus kinase 2 | RAC3 | Ras-related C3 botulinum toxin substrate 3 | −0.3199 |
| ROBO3 | Roundabout, axon guidance receptor, homolog 3 | ESM1 | Endothelial cell-specific molecule 1 | −0.6215 |
| PRKCB | Protein kinase C, beta | DLL4 | Delta-like 4 | −0.2046 |
| RBP4 | Retinol binding protein 4, plasma | RAC3 | Ras-related C3 botulinum toxin substrate 3 | −0.5189 |
| PRKCB | Protein kinase C, beta | FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor | −0.2420 |
|
